Business Context and Reporting Period
Company: Inventiva S.A.
Filing Type: Form 6-K (Report of Foreign Private Issuer)
Date: July 9, 2025
Context: This filing serves to incorporate by reference a press release issued by the registrant on July 9, 2025 (Exhibit 99.1). The registrant files annual reports under Form 20-F.
Key Financial Metrics
The provided filing text does not contain specific financial data. It acts as a cover document for a press release and does not list revenue, profit, cash flow, margins, debt, or liquidity figures.
Material Changes
The filing text does not provide details on material changes versus prior periods. The content of the referenced press release (Exhibit 99.1) is not included in the input text.
Guidance, Outlook, and Risks
The filing text does not include management commentary, guidance, outlook, risks, contingencies, or unusual items. These details would be contained within the attached press release, which is not provided in the source text.
Investor Verification Checklist
- Review the full text of the press release dated July 9, 2025 (Exhibit 99.1) to understand the specific event triggering this filing.
- Verify if the press release contains updates on clinical trial progress, regulatory approvals, or partnership agreements, as Inventiva S.A. is a biopharmaceutical company.
- Check subsequent filings for any financial impact resulting from the event described in the press release.